Immunologic Aspects of Multiple Sclerosis (Q37855723)

24 August 2017

title

Immunologic Aspects of Multiple Sclerosis (English)

1 reference

28 November 2024

0 references

Sridhar Boppana

1

1 reference

24 August 2017

Hui Huang

2

1 reference

24 August 2017

Kouichi Ito

3

1 reference

24 August 2017

Suhayl Dhib-Jalbut

4

1 reference

24 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21425265

28 November 2024

publication date

1 March 2011

1 reference

24 August 2017

March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21425265

full work available at URL

28 November 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsj.20249

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/msj.20249

28 November 2024

1 reference

Mount Sinai Journal of Medicine

28 November 2024

published in

1 reference

24 August 2017

volume

78

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

207-220

1 reference

Multiple sclerosis genetics--is the glass half full, or half empty?

24 August 2017

cites work

1 reference

Multiple sclerosis and the major histocompatibility complex.

21 January 2018

1 reference

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

Autoimmune T cell responses in the central nervous system

21 January 2018

1 reference

EAE: an immunologist's magic eye.

21 January 2018

1 reference

The role of antigen presenting cells in multiple sclerosis

21 January 2018

1 reference

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

21 January 2018

1 reference

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

21 January 2018

1 reference

Multiple sclerosis in Italy. A reappraisal of incidence and prevalence in Ferrara

21 January 2018

1 reference

Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk

21 January 2018

1 reference

B cells and multiple sclerosis

21 January 2018

1 reference

Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms

21 January 2018

1 reference

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary

21 January 2018

1 reference

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis.

21 January 2018

1 reference

Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes

21 January 2018

1 reference

Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood

21 January 2018

1 reference

Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes

21 January 2018

1 reference

The role of CD4 T cells in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis

21 January 2018

1 reference

Multiple sclerosis -- a coordinated immune attack across the blood brain barrier

21 January 2018

1 reference

The role of CD4+ T-cells in the development of MS.

21 January 2018

1 reference

Interleukin-17--extended features of a key player in multiple sclerosis

21 January 2018

1 reference

Th17 cells in human disease.

21 January 2018

1 reference

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

21 January 2018

1 reference

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

Immunology: In the beginning

21 January 2018

1 reference

Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.

21 January 2018

1 reference

Th17/Th1 phenotype in demyelinating disease

21 January 2018

1 reference

The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity

21 January 2018

1 reference

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

21 January 2018

1 reference

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

21 January 2018

1 reference

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

21 January 2018

1 reference

Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.

21 January 2018

1 reference

Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40)

21 January 2018

1 reference

21 January 2018

Th9 and allergic disease

1 reference

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells

21 January 2018

1 reference

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

21 January 2018

1 reference

Identification of an immediate Foxp3(-) precursor to Foxp3(+) regulatory T cells in peripheral lymphoid organs of nonmanipulated mice

21 January 2018

1 reference

Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis

21 January 2018

1 reference

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

21 January 2018

1 reference

Disturbed regulatory T cell homeostasis in multiple sclerosis.

21 January 2018

1 reference

CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis

21 January 2018

1 reference

Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

21 January 2018

1 reference

Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.

21 January 2018

1 reference

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells

21 January 2018

1 reference

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

21 January 2018

1 reference

Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.

21 January 2018

1 reference

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

Homogeneity of active demyelinating lesions in established multiple sclerosis

21 January 2018

1 reference

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

21 January 2018

1 reference

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

21 January 2018

1 reference

Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

21 January 2018

1 reference

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis

21 January 2018

1 reference

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

21 January 2018

1 reference

Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis

21 January 2018

1 reference

Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis

21 January 2018

1 reference

Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation

21 January 2018

1 reference

EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN.

21 January 2018

1 reference

Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.

21 January 2018

1 reference

Role of EBERs in the pathogenesis of EBV infection

21 January 2018

1 reference

Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Taking dendritic cells into medicine

21 January 2018

1 reference

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

The role of dendritic cells in CNS autoimmunity

21 January 2018

1 reference

Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity.

21 January 2018

1 reference

A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis

21 January 2018

1 reference

Immunomodulatory effects of IFN-beta and lovastatin on immunophenotype of monocyte-derived dendritic cells in multiple sclerosis

21 January 2018

1 reference

Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis

21 January 2018

1 reference

Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.

21 January 2018

1 reference

Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.

21 January 2018

1 reference

Type II monocytes modulate T cell-mediated central nervous system autoimmune disease

21 January 2018

1 reference

Confirmation of association between multiple sclerosis and CYP27B1

21 January 2018

1 reference

Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis.

21 January 2018

1 reference

CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation.

21 January 2018

1 reference

Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

21 January 2018

1 reference

Interferon-beta mechanisms of action in multiple sclerosis

21 January 2018

1 reference

Overlapping and distinct mechanisms of action of multiple sclerosis therapies.

21 January 2018

1 reference

Multiple sclerosis in the province of Ferrara : evidence for an increasing trend

21 January 2018

11

1 reference

Emerging challenges in regulatory T cell function and biology

28 November 2024

15

1 reference

Vulnerability of human neurons to T cell-mediated cytotoxicity

28 November 2024

22

1 reference

T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity

28 November 2024

27

1 reference

Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients

28 November 2024

50

1 reference

CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients

28 November 2024

51

1 reference

Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis

28 November 2024

52

1 reference

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis

28 November 2024

57

1 reference

Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis

28 November 2024

64

1 reference

Primary infection with the Epstein-Barr virus and risk of multiple sclerosis

28 November 2024

68

1 reference

Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells

28 November 2024

83

1 reference

Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response

28 November 2024

84

1 reference

Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE

28 November 2024

94

1 reference

28 November 2024

Identifiers

DOI

10.1002/MSJ.20249

1 reference

24 August 2017

1 reference